| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/04/2015 | EP2841109A1 Prodrugs of hydroxyl-comprising drugs |
| 03/04/2015 | EP2841108A1 Silk microspheres and methods for surface lubrication |
| 03/04/2015 | EP2841107A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use |
| 03/04/2015 | EP2841106A1 Topical formulation compositions containing silicone based excipients to deliver actives to a substrate |
| 03/04/2015 | EP2841105A1 Magnesium phosphate gels |
| 03/04/2015 | EP2841054A1 Injectable preparation |
| 03/03/2015 | US8969626 Reagents and method for conjugating biological molecules |
| 03/03/2015 | US8969622 Dendritic molecular intracellular transporters and methods of making and using same |
| 03/03/2015 | US8969532 Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| 03/03/2015 | US8969517 Method for processing vegetable raw materials |
| 03/03/2015 | US8969515 Pharmaceutical composition for treating hyperproliferative diseases |
| 03/03/2015 | US8969514 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 03/03/2015 | US8969473 Compounds and medical devices activated with solvophobic linkers |
| 03/03/2015 | US8969411 Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same |
| 03/03/2015 | US8969379 Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
| 03/03/2015 | US8969354 Fatty acid fumarate derivatives and their uses |
| 03/03/2015 | US8969353 Aminoalcohol lipidoids and uses thereof |
| 03/03/2015 | US8969337 Prodrugs of secondary amine compounds |
| 03/03/2015 | US8969320 Hyaluronic acid derivatives containing groups able to release NO |
| 03/03/2015 | US8969319 Agent for applying to mucosa and method for the production thereof |
| 03/03/2015 | US8969310 Potentiation of anticancer agents |
| 03/03/2015 | US8969307 Cyclosporin compositions |
| 03/03/2015 | US8969305 Aqueous ophthalmic solution based on cyclosporin |
| 03/03/2015 | US8969298 Liquid preparation of physiologically active peptide |
| 03/03/2015 | US8969292 High affinity leptins and leptin antagonists |
| 03/03/2015 | US8969289 Serum albumin binding molecules |
| 03/03/2015 | US8968790 Nanoformulation of vitamin D derivatives and/or vitamin D metabolites |
| 03/03/2015 | US8968784 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery |
| 03/03/2015 | US8968783 Hydrogel implants with varying degrees of crosslinking |
| 03/03/2015 | US8968782 Combination degradable and non-degradable matrices for active agent delivery |
| 03/03/2015 | US8968775 Microemulsion topical delivery platform |
| 03/03/2015 | US8968769 Orally disintegrative dosage form |
| 03/03/2015 | US8968768 Phytosterol nutritional supplements |
| 03/03/2015 | US8968753 Ceftolozane-tazobactam pharmaceutical compositions |
| 03/03/2015 | US8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 03/03/2015 | US8968744 Aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 03/03/2015 | US8968742 Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
| 03/03/2015 | US8968741 Anti-CD22 antibodies and immunoconjugates and methods of use |
| 03/03/2015 | US8968725 Genipin cross-linked fibrin gels |
| 03/03/2015 | US8968714 Carrier nanoparticles and related compositions, methods and systems |
| 03/03/2015 | US8968710 Topical anesthetic |
| 02/26/2015 | WO2015027136A1 Urease inhibitor and non-ufp solid carrier composition |
| 02/26/2015 | WO2015027054A2 Telodendrimers and nanocarriers and methods of using same |
| 02/26/2015 | WO2015026907A1 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | WO2015026851A1 Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate |
| 02/26/2015 | WO2015026225A1 Bilayer hydrocolloid films containing therapeutic agents |
| 02/26/2015 | WO2015026054A1 Sidenafil citrate orally disintegrating film formulation with improved dispersibility and method for formulating same |
| 02/26/2015 | WO2015025979A1 Method for producing microparticles |
| 02/26/2015 | WO2015025935A1 Cataplasm and method for producing same |
| 02/26/2015 | WO2015025815A1 Polyrotaxane and medicinal composition |
| 02/26/2015 | WO2015025767A1 Transdermal patch |
| 02/26/2015 | WO2015025766A1 Transdermal patch |
| 02/26/2015 | WO2015025718A1 Adhesive patch |
| 02/26/2015 | WO2015025217A2 Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides |
| 02/26/2015 | WO2015025000A1 Pharmaceutical compositions comprising bortezomib |
| 02/26/2015 | WO2015024931A1 Peptidic nanodelivery composition targeting two receptors |
| 02/26/2015 | WO2015024217A1 Chlorogenic acid powder-injection and preparation method thereof |
| 02/26/2015 | WO2015024063A1 Formation of sub-nano metal particles |
| 02/26/2015 | US20150057605 Stable Glucagon Peptide Formulations |
| 02/26/2015 | US20150057375 Use of improved n-alkyl pyrrolidone solvent |
| 02/26/2015 | US20150057374 Material, method for preparing same, and uses thereof |
| 02/26/2015 | US20150057373 DIETHER BASED BIODEGRADABLE CATIONIC LIPIDS FOR siRNA DELIVERY |
| 02/26/2015 | US20150057370 Drug composition and soft capsule drug sealing the drug composition |
| 02/26/2015 | US20150057368 Closed cell foams including poly-4-hydroxybutyrate and copolymers thereof |
| 02/26/2015 | US20150057362 Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition |
| 02/26/2015 | US20150057360 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 02/26/2015 | US20150057356 Melt-extruded composition comprising a cellulose ether |
| 02/26/2015 | US20150057343 AGONISTS OF THE AhR RECEPTOR PATHWAY HAVING SEBOSUPPRESSIVE ACTIVITY AND A METHOD FOR IDENTIFYING SAID AGONISTS |
| 02/26/2015 | US20150057339 High molecular weight arginine-grafted bioreducible polymers |
| 02/26/2015 | US20150057327 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/26/2015 | US20150057321 Soft chewable pharmaceutical products |
| 02/26/2015 | US20150057305 Pharmaceutical composition |
| 02/26/2015 | US20150057296 Novel pharmaceutical dosage forms comprising valganciclovir hydrochloride |
| 02/26/2015 | US20150057284 Method and improved pharmaceutical composition for enhancing transdermal delivery of pde-5 inhibitor |
| 02/26/2015 | US20150057266 Pharmaceutical Composition Having Improved Dissolution Profiles For Poorly Soluble Drugs |
| 02/26/2015 | US20150057259 Stabilized compositions containing alkaline labile drugs |
| 02/26/2015 | US20150057252 Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate |
| 02/26/2015 | US20150057249 Vesicular Formulations |
| 02/26/2015 | US20150057245 Use of lipid conjugates in the treatment of inflammatory disorders |
| 02/26/2015 | US20150057244 Use of lipid conjugates in the treatment of disease |
| 02/26/2015 | US20150057239 Solid oral pharmaceutical compositions for isoxazoline compounds |
| 02/26/2015 | US20150057221 Prodrug comprising a drug linker conjugate |
| 02/26/2015 | US20150057219 Reversible pegylated drugs |
| 02/26/2015 | US20150056307 Method, composition and package for bowel cleansing |
| 02/26/2015 | US20150056300 Therapeutic nanoparticles with high molecular weight copolymers |
| 02/26/2015 | US20150056288 Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan |
| 02/26/2015 | US20150056287 Nanoparticulate megestrol formulations |
| 02/26/2015 | US20150056274 Compositions, methods and kits for reducing lipid levels |
| 02/26/2015 | US20150056273 Microbubble ultrasound contrast agent for external use |
| 02/26/2015 | US20150056272 Synergistic Antimicrobial Preparations Containing Chlorite and Hydrogen Peroxide |
| 02/26/2015 | US20150056270 Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside |
| 02/26/2015 | US20150056268 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| 02/26/2015 | US20150056254 Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same |
| 02/26/2015 | US20150056223 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 02/26/2015 | US20150056222 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | US20150056221 Anti-prlr antibodies and uses thereof |
| 02/26/2015 | US20150056220 Methods for identification of sites for igg conjugation |
| 02/26/2015 | US20150056219 Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors |
| 02/26/2015 | US20150056218 P97 fragments with transfer activity |
| 02/26/2015 | US20150056158 Branched polymers |